Postdoctoral Training

There is a common core of knowledge, skills, and experiences to engage meaningfully in the field of informatics. CHIP offers training at many levels and is well integrated with the vibrant academic community at the Harvard Department for Biomedical Informatics and affiliated hospital-based training programs, providing fellows with many opportunities for interaction and collaboration.

The Computational Health Informatics Program (CHIP) at Boston Children’s Hospital hosts a training program for postdoctoral fellows to be trained in Informatics, Genomics, Machine Learning, Artificial Intelligence, and Biomedical Data Science.

The Health Natural Language Processing Lab at Boston Children’s Hospital is seeking a post-doctoral research fellow to contribute to cutting edge research in the field of health natural language processing.


The Boston Children's Hospital Computational Health Informatics Program (CHIP) is Harvard Medical School affiliated, multidisciplinary applied research and education program. CHIP is uniquely positioned at the nexus of a world-leading children’s hospital, a first-rate academic institution, wider health networks, and thoughtful collaborations with industry.

Our research has been at the forefront of posing a wide spectrum of health questions and building solutions. Our faculty advance the science of biomedical informatics for molecular characterization of the patient, gene discovery, medical decision making, diagnosis, therapeutic selection, care redesign, public health management, population health, and re-imagined clinical trials. Our research has influenced public health policies at the highest level. Governmental health institutions, like the Centers for Disease Control and Prevention, have amended their recommendations for population health based on the research of our faculty. Our faculty have advised governments worldwide on establishing biodefense and biosurveillance infrastructures. The White House, US State Department, USAID, and NASA have recognized our faculty for their research contributions in health care.

CHIP has a longstanding track record of developing and repurposing existing technologies that have been widely commercialized. We have established partnerships with  companies like Uber, Lyft, Quest Diagnostics, and Eli Lily and have developed platforms that have been widely adopted by Apple, Google, Microsoft, and Amazon.

The CHIP AI Internship is an opportunity for undergraduate students at Harvard College to develop new machine learning and artificial intelligence approaches and apply them to fundamental challenges in biomedicine.

Project Advocacy Interns will support the team in promoting projects, social media, compiling reports, working on event logistics, and pulling campaign metrics.


Diao JA, Powe NR, Manrai AK. Race-Free Equations for eGFR: Comparing Effects on CKD Classification. Journal of the American Society of Nephrology : JASN 2021.

Plana D, Tian E, Cramer AK, Yang H, Carmack MM, Sinha MS, Bourgeois FT, Yu SH, Masse P, Boyer J, Kim M, Mo J, LeBoeuf NR, Li J, Sorger PK. Assessing the filtration efficiency and regulatory status of N95s and nontraditional filtering face-piece respirators available during the COVID-19 pandemic. BMC infectious diseases 2021.

Cromwell EA, Osborne JCP, Unnasch TR, Basáñez MG, Gass KM, Barbre KA, Hill E, Johnson KB, Donkers KM, Shirude S, Schmidt CA, Adekanmbi V, Adetokunboh OO, Afarideh M, Ahmadpour E, Ahmed MB, Akalu TY, Al-Aly Z, Alanezi FM, Alanzi TM, Alipour V, Andrei CL, Ansari F, Ansha MG, Anvari D, Appiah SCY, Arabloo J, Arnold BF, Ausloos M, Ayanore MA, Baig AA, Banach M, Barac A, Bärnighausen TW, Bayati M, Bhattacharyya K, Bhutta ZA, Bibi S, Bijani A, Bohlouli S, Bohluli M, Brady OJ, Bragazzi NL, Butt ZA, Carvalho F, Chatterjee S, Chattu VK, Chattu SK, Cormier NM, Dahlawi SMA, Damiani G, Daoud F, Darwesh AM, Daryani A, Deribe K, Dharmaratne SD, Diaz D, Do HT, El Sayed Zaki M, El Tantawi M, Elemineh DA, Faraj A, Fasihi Harandi M, Fatahi Y, Feigin VL, Fernandes E, Foigt NA, Foroutan M, Franklin RC, Gubari MIM, Guido D, Guo Y, Haj-Mirzaian A, Hamagharib Abdullah K, Hamidi S, Herteliu C, Hidru HD, Higazi TB, Hossain N, Hosseinzadeh M, Househ M, Ilesanmi OS, Ilic MD, Ilic IM, Iqbal U, Irvani SSN, Jha RP, Joukar F, Jozwiak JJ, Kabir Z, Kalankesh LR, Kalhor R, Karami Matin B, Karimi SE, Kasaeian A, Kavetskyy T, Kayode GA, Kazemi Karyani A, Kelbore AG, Keramati M, Khalilov R, Khan EA, Khan MNN, Khatab K, Khater MM, Kianipour N, Kibret KT, Kim YJ, Kosen S, Krohn KJ, Kusuma D, La Vecchia C, Lansingh VC, Lee PH, LeGrand KE, Li S, Longbottom J, Magdy Abd El Razek H, Magdy Abd El Razek M, Maleki A, Mamun AA, Manafi A, Manafi N, Mansournia MA, Martins-Melo FR, Mazidi M, McAlinden C, Meharie BG, Mendoza W, Mengesha EW, Mengistu DT, Mereta ST, Mestrovic T, Miller TR, Miri M, Moghadaszadeh M, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Moradi M, Moradzadeh R, Moraga P, Mosser JF, Naderi M, Nagarajan AJ, Naik G, Negoi I, Nguyen CT, Nguyen HLT, Nguyen TH, Nikbakhsh R, Oancea B, Olagunju TO, Olagunju AT, Omar Bali A, Onwujekwe OE, Pana A, Pourjafar H, Rahim F, Rahman MHU, Rathi P, Rawaf S, Rawaf DL, Rawassizadeh R, Resnikoff S, Reta MA, Rezapour A, Rubagotti E, Rubino S, Sadeghi E, Saghafipour A, Sajadi SM, Samy AM, Sarmiento-Suárez R, Sawhney M, Schipp MF, Shaheen AA, Shaikh MA, Shamsizadeh M, Sharafi K, Sheikh A, Shetty BSK, Shin JI, Shivakumar KM, Simonetti B, Singh JA, Skiadaresi E, Soheili A, Soltani S, Spurlock EE, Sufiyan MB, Tabuchi T, Tapak L, Thompson RL, Thomson AJ, Traini E, Tran BX, Ullah I, Ullah S, Uneke CJ, Unnikrishnan B, Uthman OA, Vinkeles Melchers NVS, Violante FS, Wolde HF, Wonde TE, Yamada T, Yaya S, Yazdi-Feyzabadi V, Yip P, Yonemoto N, Yousof HSA, Yu C, Yu Y, Yusefzadeh H, Zaki L, Zaman SB, Zamanian M, Zhang ZJ, Zhang Y, Ziapour A, Hay SI, Pigott DM. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning. PLoS neglected tropical diseases 2021.

Hutch MR, Liu M, Avillach P, , Luo Y, Bourgeois FT. National Trends in Disease Activity for COVID-19 Among Children in the US. Frontiers in pediatrics 2021.